We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
-4.69%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$1.82B
AUM Growth
-$206M
Cap. Flow
-$49M
Cap. Flow %
-2.7%
Top 10 Hldgs %
31.37%
Holding
196
New
13
Increased
107
Reduced
57
Closed
16

Sector Composition

Rank Sector Weight
1 Technology 34.3%
2 Healthcare 19.73%
3 Industrials 13.65%
4 Consumer Discretionary 10.97%
5 Real Estate 5.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDWR icon
101
Radware
RDWR
$1.19B
$3.81M 0.21%
156,954
-1,052
-0.7% -$26.3K
QTS
102
DELISTED
QTS REALTY TRUST, INC.
QTS
$3.79M 0.21%
73,747
-16,458
-18% -$783K
AUTL
103
Autolus Therapeutics
AUTL
$562M
$3.78M 0.21%
304,615
+28,794
+10% +$381K
WNS
104
DELISTED
WNS Holdings
WNS
$3.54M 0.19%
60,195
-1,244
-2% -$76K
GNFT
105
DELISTED
Genfit
GNFT
$3.48M 0.19%
199,695
+8,495
+4% +$149K
ICPT
106
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$3.45M 0.19%
51,968
+3,663
+8% +$246K
IPHI
107
DELISTED
INPHI CORPORATION
IPHI
$3.42M 0.19%
56,063
-1,992
-3% -$121K
MINI
108
DELISTED
Mobile Mini Inc
MINI
$3.41M 0.19%
92,529
+9,542
+11% +$311K
DXCM icon
109
DexCom
DXCM
$32B
$3.4M 0.19%
91,000
+8,488
+10% +$330K
CTSO icon
110
Cytosorbents Corp
CTSO
$22.6M
$3.34M 0.18%
664,704
+268,829
+68% +$1.56M
VCYT icon
111
Veracyte
VCYT
$3.8B
$3.24M 0.18%
135,050
+36,856
+38% +$980K
REI icon
112
Ring Energy
REI
$339M
$3.21M 0.18%
1,959,701
+478,428
+32% +$1.03M
KIDS icon
113
OrthoPediatrics
KIDS
$595M
$3.17M 0.17%
89,874
+21,709
+32% +$752K
OKTA icon
114
Okta
OKTA
$25.8B
$3.12M 0.17%
31,637
-60
-0.2% -$7.49K
NTNX icon
115
Nutanix
NTNX
$16.9B
$3.07M 0.17%
116,853
+34,141
+41% +$805K
GMED icon
116
Globus Medical
GMED
$11.2B
$3.03M 0.17%
59,344
+16,428
+38% +$782K
QLYS icon
117
Qualys
QLYS
$6.35B
$3.01M 0.17%
39,810
-704
-2% -$58.7K
ECPG icon
118
Encore Capital Group
ECPG
$2.13B
$2.93M 0.16%
87,793
+24,770
+39% +$870K
TER icon
119
Teradyne
TER
$59.3B
$2.91M 0.16%
50,195
-3,842
-7% -$203K
MGNX icon
120
MacroGenics
MGNX
$257M
$2.86M 0.16%
224,256
+9,841
+5% +$142K
CTG
121
DELISTED
Computer Task Group, Inc.
CTG
$2.86M 0.16%
571,961
+10,062
+2% +$45.1K
LAB icon
122
Standard BioTools
LAB
$314M
$2.76M 0.15%
596,879
-138,509
-19% -$1.09M
CYBR
123
DELISTED
CyberArk
CYBR
$2.74M 0.15%
27,413
-1,097
-4% -$132K
TTGT icon
124
TechTarget
TTGT
$278M
$2.69M 0.15%
119,362
+178
+0.1% +$4.09K
BGC icon
125
BGC Group
BGC
$4.89B
$2.5M 0.14%
454,432
-33,637
-7% -$180K

Similar funds

Granahan Investment Management's Q3 2019 Portfolio in Review

As of Q3 2019, Granahan Investment Management held 196 positions worth $1.82B, down 10% from $2.02B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Granahan Investment Management's Q3 2019 filing shows 13 new, 107 increased, 57 reduced and 16 closed positions. Its largest new stake was Pluralsight, Inc. Class A Common Stock: 964,081 shares worth $16.2M. The largest sale was Coupa Software Incorporated, an estimated $27.8M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 37% a quarter earlier, followed by Healthcare and Industrials.

  • Granahan Investment Management's largest Q3 2019 buy was Pluralsight, Inc. Class A Common Stock: 964,081 shares worth $16.2M.
  • Granahan Investment Management added most to Enphase Energy in Q3 2019, an estimated $23.1M increase.
  • Granahan Investment Management's biggest Q3 2019 reduction was Coupa Software Incorporated, cutting an estimated $27.8M.
  • Granahan Investment Management fully exited Trade Desk in Q3 2019, selling an estimated $25.9M.
  • Granahan Investment Management's ten largest holdings make up 31% of its $1.82B portfolio in Q3 2019.
  • Granahan Investment Management opened 13 new positions and closed 16 in Q3 2019.
  • Granahan Investment Management's portfolio value fell 10% quarter-over-quarter to $1.82B.

Based on Granahan Investment Management's 13F filing for Q3 2019, filed 15 Nov 2019.